semaglutide causing thyroid cancer No Increased Risk for in Diabetic Patients Prescribed GLP-1 Medications Compared to Those Prescribed Insulin New Research Challenges Fears of

primarily investigated the cardiovascular outcomes of semaglutide in 3,297 patients with type 2 diabetes assigned randomly who were at high cardiovascular risk [18]

Kanda, R

Keeping it at the right temperature, away from direct sunlight, and following any specific instructions on the packaging can help preserve the medication

Beyond semaglutide, other innovative GLP-1 receptor agonist medications, such as Tirzepatide , which is also a GIP receptor agonist, are available and FDA-approved for once-weekly administration under brand names like Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)

Treatment for Blood Clots If a blood clot is confirmed, treatment will begin immediately

Combining Wegovy with other blood sugar-lowering drugs increases the risk of hypoglycemia